loadpatents
Patent applications and USPTO patent grants for Von Andrian; Ulrich.The latest application filed is for "nanoparticle-based compositions".
Patent | Date |
---|---|
Nanoparticle-based Compositions App 20200215179 - Stary; Georg ;   et al. | 2020-07-09 |
Amphiphile-Polymer Particles App 20200206145 - Shi; Jinjun ;   et al. | 2020-07-02 |
Amphiphile-polymer particles Grant 10,583,091 - Shi , et al. | 2020-03-10 |
Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders App 20180142017 - Hamrah; Pedram ;   et al. | 2018-05-24 |
Modulation of NK cell antigen specific effector activity by modulation of CXCR6 (CD186) Grant 9,872,905 - Von Andrian , et al. January 23, 2 | 2018-01-23 |
Amphiphile-Polymer Particles App 20170304213 - Shi; Jinjun ;   et al. | 2017-10-26 |
Adjuvant incorporation in immunoanotherapeutics Grant 9,439,859 - Alexis , et al. September 13, 2 | 2016-09-13 |
Adjuvant incorporation in immunonanotherapeutics Grant 9,233,072 - Alexis , et al. January 12, 2 | 2016-01-12 |
Nicotine immunonanotherapeutics Grant 8,932,595 - Iannacone , et al. January 13, 2 | 2015-01-13 |
Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders App 20150010563 - Hamrah; Pedram ;   et al. | 2015-01-08 |
Immunonanotherapeutics that provide IGG humoral response without T-cell antigen Grant 8,906,381 - Iannacone , et al. December 9, 2 | 2014-12-09 |
Adjuvant Incorporation in Immunonanotherapeutics App 20140127301 - Alexis; Frank ;   et al. | 2014-05-08 |
Adjuvant incorporation in immunonanotherapeutics Grant 8,637,028 - Alexis , et al. January 28, 2 | 2014-01-28 |
Nicotine immunonanotherapeutics Grant 8,591,905 - von Andrian , et al. November 26, 2 | 2013-11-26 |
Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,562,998 - Shi , et al. October 22, 2 | 2013-10-22 |
Induced Dendritic Cell Compositions And Uses Thereof App 20130195919 - Von Andrian; Ulrich ;   et al. | 2013-08-01 |
Modulation Of Nk Cell Antigen Specific Effector Activity By Modulation Of Cxcr6 (cd186) App 20130101597 - Von Andrian; Ulrich ;   et al. | 2013-04-25 |
Adjuvant incorporation in immunonanotherapeutics Grant 8,343,498 - Alexis , et al. January 1, 2 | 2013-01-01 |
Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,343,497 - Shi , et al. January 1, 2 | 2013-01-01 |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen Grant 8,277,812 - Iannacone , et al. October 2, 2 | 2012-10-02 |
IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN App 20120087890 - Iannacone; Matteo ;   et al. | 2012-04-12 |
Adjuvant Incorporation In Immunonanotherapeutics App 20110268805 - Alexis; Frank ;   et al. | 2011-11-03 |
Targeting Of Antigen Presenting Cells With Immunonanotherapeutics App 20110268804 - Shi; Jinjun ;   et al. | 2011-11-03 |
Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen App 20100183727 - Iannacone; Matteo ;   et al. | 2010-07-22 |
Adjuvant Incorporation in Immunonanotherapeutics App 20100129439 - Alexis; Frank ;   et al. | 2010-05-27 |
Targeting of Antigen Presenting Cells with Immunonanotherapeutics App 20100129392 - Shi; Jinjun ;   et al. | 2010-05-27 |
Nicotine Immunonanotherapeutics App 20100092425 - von Andrian; Ulrich ;   et al. | 2010-04-15 |
Methods for enhancing thrombolysis in a mammal Grant 6,191,103 - Shohet , et al. February 20, 2 | 2001-02-20 |
NCAGE Code | 461Q8 | VON ANDRIAN ULRICH |
CAGE Code | 461Q8 | VON ANDRIAN, ULRICH |
SEC | 0001677544 | von Andrian Ulrich |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.